Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at having imatinib for 3 or 5 years for gastrointestinal stromal tumour (SSG XXII)

Overview

Cancer types:

Sarcoma, Soft tissue sarcoma

Status:

Closed

Phase:

Phase 3

Details

This trial is for people with gastrointestinal stromal tumour (GIST) who have had surgery and taken imatinib for 3 years.

Cancer Research UK supports this trial.

Recruitment start: 11 January 2017

Recruitment end: 30 September 2022

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Ramesh Bulusu

Supported by

Cambridge University Hospitals NHS Foundation Trust

Cancer Research UK

Novartis

Scandinavian Sarcoma Group (SSG)

GIST Cancer UK

Other information

This is Cancer Research UK trial number CRUK/15/073

Last reviewed: 11 September 2024

CRUK internal database number: 13390

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.